Nuveen Asset Management, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 154 filers reported holding REATA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$9,588,216
+94804.6%
94,039
-15.4%
0.00%
-25.0%
Q1 2023$10,103
+148.3%
111,121
+3.7%
0.00%
+100.0%
Q4 2022$4,069
-99.9%
107,115
-3.0%
0.00%
+100.0%
Q3 2022$2,775,000
-19.7%
110,433
-2.8%
0.00%0.0%
Q2 2022$3,454,000
-13.4%
113,646
+7.7%
0.00%0.0%
Q1 2022$3,987,000
+55.2%
105,532
+8.3%
0.00%0.0%
Q4 2021$2,569,000
-75.6%
97,415
-7.1%
0.00%
-66.7%
Q3 2021$10,548,000
-55.2%
104,836
-37.0%
0.00%
-57.1%
Q2 2021$23,561,000
+83.9%
166,467
+29.5%
0.01%
+75.0%
Q1 2021$12,813,000
-18.1%
128,506
+1.6%
0.00%
-20.0%
Q4 2020$15,639,000
+58.6%
126,505
+25.0%
0.01%
+25.0%
Q3 2020$9,861,000
-43.0%
101,220
-8.8%
0.00%
-42.9%
Q2 2020$17,315,000
-36.5%
110,980
-41.2%
0.01%
-46.2%
Q1 2020$27,262,000
-18.6%
188,875
+15.2%
0.01%0.0%
Q4 2019$33,511,000
+139.6%
163,926
-5.9%
0.01%
+116.7%
Q3 2019$13,984,000
+9.5%
174,165
+28.7%
0.01%
+20.0%
Q2 2019$12,767,000
+2998.8%
135,312
+2708.5%
0.01%
+150.0%
Q1 2019$412,0004,8180.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders